Yuki Yamamoto

10PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Wastewater treatment processesImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 25, 2026
Efficacy, Safety, and Predictive Value of Quantitative Histopathology in Picosecond Laser Therapy for Congenital Melanocytic Nevi: A Prospective Clinical Trial.

|Apr 04, 2025
Adjuvant Anti-PD-1 Monotherapy Versus Observation for Stage III Acral Melanoma of the Sole: A Multicenter Retrospective Study in Japanese Patients.

Shigeru Koizumi, Naoya Yamazaki, Yuki Ichigozaki

|Mar 05, 2025
Topical sirolimus therapy for cutaneous vascular anomalies: A randomized phase II clinical trial.

Masatoshi Jinnin, Toshio Shimokawa, Akiko Kishi

|Jul 31, 2023
Adverse events associated with postoperative outcomes of adjuvant anti-PD-1 antibody therapy in both acral and non-acral cutaneous melanomas: A multicenter, observational, post hoc analysis study.

Yusuke Muto, Yumi Kambayashi, Hiroshi Kato

|Jun 27, 2023
Glycoprotein M6A upregulation detected by transcriptome analysis controls the proliferation of keloidal fibroblasts.

Mana Kurimoto-Nishiguchi, Kyoko Muraoka, Yutaka Inaba

|May 20, 2023
Clinical evaluation of needle-free electronic pneumatic hyaluronic acid injection treatment for facial atrophic acne scars: A prospective, randomized comparative trial.

Chikako Kaminaka, Mariko Sakata, Mana Nishiguchi

Pageof 2

Frequent Collaborators

6 joint publications

Kayo Kunimoto

5 joint publications

Masatoshi Jinnin

4 joint publications

Chikako Kaminaka

4 joint publications

Mariko Sakata